Target intelligence / Profile preview

Gamma-aminobutyric acid receptor-associated protein-like 2 (GABARAPL2)

Target
GABARAPL2
Molecular classification
Ubiquitin-like modifier, Autophagy-related protein (ATG8 family), Vesicle trafficking/modifier protein ("Other")
01

Overview

Gamma-aminobutyric acid receptor-associated protein-like 2 (GABARAPL2) is a ubiquitin-like modifier and autophagy-related protein belonging to the ATG8 family, encoded by the GABARAPL2 gene in humans[2][4][5]. GABARAPL2 is involved in several critical cellular processes, most notably the maturation of autophagosomes (a structure important for cellular autophagy), intra-Golgi traffic, and regulation of mitophagy[2]. GABARAPL2 binds to phosphatidylethanolamine and ubiquitin protein ligases and interacts with proteins such as ULK1, ATG4B, FAM134B, and UBA5 via LC3-interacting regions (LIRs)[2][3][4]. Its biological roles center on protein trafficking, autophagosome maturation, and negative regulation of proteasomal protein degradation. GABARAPL2 has disease links to conditions involving dysfunctional autophagy, including certain neurodegenerative diseases and cancers, though direct drug targeting or biomarker use is not established as of current knowledge[2][4]. Note: GABARAPL2 does not directly bind GABA type A receptors (despite its name)—that function is attributed to the related proteins GABARAP and GABARAPL1[1].

Other names
ATG8ATG8CGATE-16GATE16GEF-2GEF2FLC3ALC3Ganglioside expression factor 2General protein transport factor p16Golgi-associated ATPase enhancer of 16 kDaMAP1 light chain 3-related protein
02

Biological functions

AutophagyMitophagyVesicle-mediated transportProtein localization to endoplasmic reticulumNegative regulation of proteasomal protein catabolic process
03

Disease associations

Neurodegenerative diseaseCancer (implicated via autophagic regulation)Other (e.g., congenital skeletal disorders) [Dry Eye Syndrome, Vertical Talus, Congenital]

Beyond the preview

Go deeper on Gamma-aminobutyric acid receptor-associated protein-like 2 (GABARAPL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid receptor-associated protein-like 2 (GABARAPL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call